After sealing the area of the nitrogen gas leak that left two persons dead, Dr Reddy's Laboratories (DRL) is to be served a notice on the incident that occured at its manufacturing plant at Bollaram on the outskirts of Hyderabad.
The list, posted on a website link launched by the US regulator, includes ABB, HSBC, Nokia, Unilever, Cadbury, Total and Siemens among others.
The semaglutide patent expiry next year could unleash a wave of generic versions from Indian drugmakers, with prices expected to go lower -- at least 80 per cent.
NDA constituents AIADMK and BJP have started preliminary discussions for the 2026 Tamil Nadu Assembly elections. Key leaders from both parties met to discuss strategies to defeat the DMK government and strengthen their alliance.
Dr Reddy's Laboratories, the second largest drug maker in the country, would invest about Rs 750 crore.
'Our problem is not a budget deficit but a trust deficit. We need to trust our institutions and industries to innovate and lead. That is the way forward for India.'
Take the rediff business quiz and see how much you know about India's pharmaceutical industry.
Opposition candidate B Sudershan Reddy appeals to MPs to vote with conscience in the upcoming vice presidential polls, urging them to prioritize the spirit of India and parliamentary traditions over party loyalty.
The US drug regulator raised the issue of significant deviations from the current good manufacturing practice (cGMP) in three of DRRD's plants in a letter issued in November 2015
Indian drugmaker Dr Reddy's Laboratories said on Thursday it had filed an application with the US Food and Drug Administration to market a generic form of GlaxoSmithKline's anti-nausea drug Zofran.\n\n
RSS chief Mohan Bhagwat emphasized the importance of social harmony, environmental responsibility, and national unity, urging people to rise above divisions and work collectively for the betterment of society and the nation.
'After Kohli's hundred at Ranchi, the second and third phases vanished in minutes. Nothing was left unsold.'
The combined sales of the branded versions of the products in the US is about $3.5 billion.
A three-member committee, comprising two officials from the Director of Factories and one pharma expert, will probe the gas leak at a production unit of Dr Reddy's Laboratories (DRL). The Director of Factories will appoint a pharma domain expert soon.
Despite being a doctor, Mahendra allegedly did not perform CPR. She was taken to a nearby hospital, where doctors declared her dead on arrival, Muni Reddy alleged. Postmortem and Forensic Science Laboratory (FSL) reports later confirmed the presence of anaesthetic substances in her organs, police said.
DRL launched four new products in North America during the previous quarter.
Dr Reddy's has offered a price of 0.52 euro in cash for each OctoPlus share.
The US Food and Drug Administration's (USFDA)'s new draft guidelines aimed at speeding up and reducing the cost of developing biosimilars - lower-priced, near-replicas of complex biologic medicines - could significantly benefit Indian biotech companies.
Dr Reddys Laboratories Ltd has posted a net profit of Rs 931.60 million for the quarter ended December 31, 2002 as compared to a net profit of Rs 1615.30 million in the quarter ended December 31,2001.
Pfizer Inc and its group companies filed a petition in a US court against Aurobindo Pharma Ltd and Dr Reddy's Laboratories alleging that the Indian drug-makers were planning separately to come out with generic versions of its blockbuster multi-billion dollar drug Ibrance (palbociclib) before expiration of its patent.
In November, DRL registered growth of 28 per cent year-on-year (YoY), which was the highest among peers and double that of the industry growth (14.5 per cent).
'One day my neighbour in Denver called me and said, "I think somebody is casing your house. So should I call the cops?"... they were scared that people case your house and then rob it.' 'And I said, "no, no, no. It's just that I am an actress".'
The company has launched only 3 new products during 2015 when compared to 14 launches in 2014
A drug developed by the Defence Research and Development Organisation (DRDO) may reverse the heart damage caused by a protein in the SARS-CoV-2 virus, a study conducted in fruit flies and mice has found.
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
Concerns over weakening demand for Indian pharmaceutical (pharma) drugs in the US - their largest export market - have weighed heavily on investor sentiment this year. While the Nifty 50 has gained 6.02 per cent year - to - date (as on September 15), the Nifty Pharma index has declined 5.18 per cent, National Stock Exchange data shows.
US accounts for a large part of revenue for top Indian pharma companies like Gland Pharma (54 percent), Dr Reddy's (53 per cent), and Aurobindo Pharma (48 per cent).
The Congress party extended best wishes to the newly-elected Vice President of India, C P Radhakrishnan, while also recalling the words of the first Vice President, Sarvepalli Radhakrishnan, on the importance of a strong opposition in a democracy.
Apart from favipiravir and remdesivir, its key Covid-19 products, DRL has already launched nutraceutical products and hand sanitisers during the pandemic.
'Rahul Gandhi's problem is that he doesn't think big.' 'He looks more like an activist, while politics is like a game of chess. You attack and then defend and have a game-plan.'
Karnataka Deputy Chief Minister D K Shivakumar responds to criticism regarding Bengaluru's infrastructure, while industry leaders and opposition members voice their concerns.
Trading sentiment in the stock market this week will be guided by quarterly earning announcements from blue-chips such as Infosys and Bajaj Finance, the outcome of India-US trade talks and global cues, analysts said. Markets may on Monday react to the quarterly results of three heavyweights - Reliance Industries, HDFC Bank and ICICI Bank, an expert said.
On October 2, a legislature committee wrote letters to the 14 companies, initiating an investigation and seeking details about recent price increases in several generic products available in the American market.
'Both international cooperation and self-reliance will now acquire new purpose.'
Maharashtra Governor C P Radhakrishnan reflects on his tenure as he prepares to move to Delhi as the next Vice President of India, calling it the happiest period in his public life.
Prices for Indian consumers are expected to come down significantly from the current Rs 17,000-Rs 26,000 monthly.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances